# OnCo record paper-guedes-msh2-loss-primary-prostate-ccr-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-guedes-msh2-loss-primary-prostate-ccr-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-guedes-msh2-loss-primary-prostate-ccr-2017" ;
  schema:name "MSH2 loss in primary prostate cancer"@en ;
  schema:description "Staining more than a thousand prostate tumours found the mismatch repair protein missing in about one in eighty, and twenty times more often in the highest-grade cancers."@en ;
  schema:url <https://onco.cc/key-papers/paper-guedes-msh2-loss-primary-prostate-ccr-2017/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-17-0955>, <https://pubmed.ncbi.nlm.nih.gov/28790115/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-17-0955> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Guedes LB, Antonarakis ES, Schweizer MT, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/msh2/>, <https://onco.cc/targets/mmr/> ;
  onco:pathways <https://onco.cc/pathways/mismatch-repair-msi/>, <https://onco.cc/pathways/cancer-immunity-cycle/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/lynch-syndrome/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/germline-vs-somatic/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .